Upon completion of the video presentation, to finish the activity and claim your credit, please click
here.
This activity has expired, credit is no longer available.
This activity is supported by an unrestricted educational grant from United Therapeutics
Immunotherapy for High-Risk Neuroblastoma
Rajen Mody, MD MS
University of Michigan
Elizabeth Hollenkamp, BSN, RN
University of Michigan
Rhonda McDougall, PNP
University of Michigan
Erika Mora, PharmD
University of Michigan
Break through immunotherapy for High-Risk Neuroblastoma presents challenges in administration and symptom management, which requires interprofessional collaboration and family support. This activity will present case studies that clearly define the complexities involved in treatment decisions, symptom management, guidelines for administration, and the role of the collaborative care to improve patient outcomes.
These CME/CE/CPE accredited activities are jointly provided by
